Prophylaxis of migraine with melatonin: a randomized controlled trial.
Quick navigation
Link to full study
http://www.ncbi.nlm.nih.gov/pubmed/20975054
Conclusion of this study
This study provides Class I evidence that prolonged-release melatonin (2 mg 1 hour before bedtime) does not provide any significant effect over placebo as migraine prophylaxis.
Supplements analyzed in this study
|
Health conditions analyzed in this study
|
||
|
Functions related to this study
|
||
|
Body systems related to this study
 Nervous System |
